---
title: "Eupraxia Pharmaceuticals Inc. (EPRX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/EPRX.US.md"
symbol: "EPRX.US"
name: "Eupraxia Pharmaceuticals Inc."
industry: "Biotechnology"
---

# Eupraxia Pharmaceuticals Inc. (EPRX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.eupraxiapharma.com](https://www.eupraxiapharma.com) |

## Company Profile

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. The company’s proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. Its lead ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -12.86 | 470/604 | - | - | - |
| PB | 6.99 | 345/604 | 65.39 | 7.35 | 5.32 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-23T05:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 8 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 8.05 |
| Highest Target | 19.00 |
| Lowest Target | 11.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/EPRX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/EPRX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/EPRX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.